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The complicated interactions between Leishmania and the host antigen-presenting cells
(APCs) have fundamental effects on the final outcome of the disease. Two major APCs,
macrophages and dendritic cells (DCs), play critical roles in mediating resistance and
susceptibility during Leishmania infection. Macrophages are the primary resident cell
for Leishmania: they phagocytose and permit parasite proliferation. However, these
cells are also the major effector cells to eliminate infection. The effective clearance of
parasites by macrophages depends on activation of appropriate immune response, which
is usually initiated by DCs. Here, we review the early interaction of APCs with Leishmania
parasites and how these interactions profoundly impact on the ensuing adaptive immune
response. We also discuss how the current knowledge will allow further refinement of our
understanding of the interplay between Leishmania and its hosts that leads to resistance
or susceptibility.
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INTRODUCTION
Several species of the protozoan parasites belonging to the genus
Leishmania are the causative agent of a spectrum of zoonotic
disease collectively called leishmaniasis. The disease is consid-
ered endemic in over 80 countries and about 2 million new
cases occur every year, of which approximately 50% of these
new cases are children (Bhattacharya et al., 2006). More than 12
million people are believed to be presently infected and a pop-
ulation of over 350 million people are at risk and around 7000
death annually are due to the disease (Bern et al., 2008). All
types of leishmaniasis are transmitted by the female phlebotomine
Sandflies, which infect a range of mammals including humans,
rodents, and canids (Ashford, 1996). During their relatively sim-
ple life cycle, Leishmania parasites alternate between two distinct
developmental stages: the flagellated, motile “promastigote” form
residing in the midgut of Sandfly vectors, and the non-motile
“amastigote” form that reside within phagolysosomal vesicles of
the vertebrate host macrophages.
The life cycle of Leishmania is initiated when the infected
female Sandfly injects metacyclic promastigotes into the host dur-
ing a regular blood meal. Within minutes, the promastigotes
are rapidly taken up by phagocytic cells, including macrophages
and neutrophils. Since neutrophils have a very short life
span, macrophages are the final host cells for proliferation of
Leishmania parasites (Antoine et al., 1998). After internalization
into the phagolysosome of macrophages, the promastigotes start
to differentiate into small, non-motile amastigote forms, which
Abbreviations: DC, dendritic cell; dLN, draining lymph node; LPG, lipophospho-
glycan; PG, phosphoglycan.
divide many times by binary fission, eventually rupturing the
macrophages to infect other surrounding macrophages. When
the infected host is bitten by another Sandfly, these amastigotes
are taken up with the blood meal, undergo series of morpho-
logical and developmental changes in the gut of the Sandfly and
differentiate into mature or infectious promastigote forms. Fully
differentiated infective organisms migrate to themouthpart of the
sandflies and are injected into another host during a blood meal.
INTERACTION OF LeishmaniaWITH HOST CELLS
Although Leishmania parasites interact and infect a variety of host
cell types, macrophages and dendritic cells (DCs) are arguably
the most important cells that regulate the outcome of infec-
tion. After the initial uptake and internalization of promastigotes
by macrophages into the phagosome, subsequent fusion with
lysosomes occurs, and the parasites must survive/live within
this hostile host phagolysosomal environment. Although this is
perhaps one of the most challenging environments for most
pathogens, Leishmania are among the few protozoa that can sur-
vival and multiply in such a harsh environment. Understanding
how these organisms are able to survival and manipulate host
cells to favor their replication and transmission is critically impor-
tant for designing new drugs or therapeutic strategies against the
disease. In the following discussion, we present an overview of
the Leishmania–macrophage/DC interaction and the subsequent
impact of this interaction on host immune response and disease
pathogenesis. Although we will mention the various subversion
strategies employed by the parasite to successfully proliferate in
infected cells, we will not go into details of these evasion strategies.
For more comprehensive information on these, we refer the
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reader to these recent and excellent reviews (Gregory and Olivier,
2005; Olivier et al., 2005; Soong, 2008; Xin et al., 2008; Shio et al.,
2012).
THE INTERACTION OF LeishmaniaWITH MACROPHAGES
Because Leishmania parasites are obligatory intracellular
pathogens, macrophages are indispensable for parasite survival,
replication, and differentiation. After initial infection, both
neutrophils and macrophages are recruited to the infection site
and their interaction with the parasites significantly influence
the outcome of infection (Ribeiro-Gomes et al., 2004, 2007).
However, recent studies suggest that more neutrophils are
recruited to the infection site (particularly when infection is
initiated by Sandfly bite) and these cells are very efficient in
parasite uptake (Peters et al., 2008; Peters and Sacks, 2009). Since
neutrophils are short-lived phagocytes, they are believed to serve
as intermediate host cells, and have been proposed to act as
“Trojan horses” used by parasites to hitchhike a ride in order
to silently enter macrophages thereby avoiding cell activation
(Laufs et al., 2002; van Zandbergen et al., 2004). In fact, L. major
infection of polymorphonuclear neutrophils (PMNs) leads to
significant delay in their programmed death and secretion of
high levels of MIP-1β, which is known to attract macrophages
to the site of infection (van Zandbergen et al., 2004). Once
macrophages are recruited, they phagocytose free parasites and
infected/apoptotic PMNs and become the final definitive host
cells for parasite replication as well as effector cells responsible
for the destruction of parasites.
The uptake of Leishmania promastigotes by host cells is
a classical receptor-mediated process that initiates phagocyto-
sis. A number of parasite and macrophage surface molecules
have been implicated in the interaction between Leishmania
and macrophages. In the case of promastigotes, the comple-
ment receptors (CR)1, CR3 (Mac-1), fibronectin receptor, and the
mannose-fucose receptor (MR) on the surface of macrophages
play import roles in promastigote binding/attachment (Kane and
Mosser, 2000). Interestingly, an earlier study found that indi-
vidual ligation of these receptors does not trigger the activa-
tion of macrophages, suggesting multiple receptor ligation may
be important for initiating the appropriate protective response
(Aderem and Underhill, 1999). In a recently study Ueno et al.
attempted to address the conflicting reports regarding the impor-
tance of MR in Leishmania entry into macrophages. They found
that metacyclic promastigotes of L. infantum chagasi use CR3
but not MR to enter macrophages, in contrast to avirulent pro-
mastigotes, which use both receptors to enter the cells. It is
already known that CR3 ligation by itself does not trigger NADPH
oxidase activation and subsequent respiratory burst at the phago-
some membrane (Sehgal et al., 1993), while MR ligation has been
shown to promote inflammatory responses (Linehan et al., 2000).
These results may explain why metacyclic promastigotes avoid
using detrimental MR during their invasion of macrophages in
order to enhance their intracellular survival.
The surface lipophosphoglycan (LPG), GP63, and pro-
teophophoglycans (PPG) on L. major promastigotes are also
important determinants in the initiation phagocytosis and
subsequent intracellular survival of parasites (Yao et al., 2003;
Naderer and McConville, 2008), as they are the target molecules
for various opsonins such as the degradation fragments of com-
plement component C3 (C3b/iC3b) (Brittingham and Mosser,
1996), mannose-binding protein (Green et al., 1994), and
galectins (Pelletier et al., 2003; Kamhawi et al., 2004). It is impor-
tant to remember that deficiency of a single molecule (such as
LPG) is not detrimental for attachment, because phagocytosis
of LPG mutant parasites is not compromised and may be even
better when compared to their wild type controls (McNeely and
Turco, 1990). However, while deficiency of LPG does not affect
phagocytosis, it significantly impacts on the intracellular survival
of these mutants (McNeely and Turco, 1990), suggesting these
molecules are still critical for inhibiting and subverting the host
killing machinery. In the case of amastigote stage of Leishmania,
it has been demonstrated that host IgG-coated parasites could
bind to Fc receptors (FcγR) on macrophages to facilitate entry
into these cells. This engagement and subsequent entry activate
downstream signaling pathways that prevent killing and promote
intracellular parasite growth (Miles et al., 2005).
Macrophages are also the major effector cells responsible for
destruction of the parasites. Macrophages can be activated by dif-
ferent signals leading to their development into functionally dis-
tinct subsets with different disease outcomes. Thus, appropriate
activation of macrophages is crucial for eliminating this intracel-
lular pathogen. Macrophage activation is generally divided into
two functionally distinct spectra: classical and alternative activa-
tion (Figure 1). Classical activation is mediated by the products
of Th1 and NK cells—in particular, IFN-γ, which stimulates
macrophages to produce inducible nitric oxide synthase (iNOS,
also known as NOS2), an enzyme which catalyzes L-arginine to
generate nitric oxide (NO) (Liew et al., 1990). NO is a toxic
molecule that plays a major role in killing intracellular parasites,
including Leishmania. In the absence of IFN-γ or microbial prod-
ucts such as LPS, iNOS mRNA, and protein are undetectable in
macrophages (Santos et al., 2006), suggesting a critical role for
IFN-γ in macrophage activation. The importance of iNOS in
facilitating parasite control is further supported by the finding
that iNOS deficient mice on a normally resistant background are
highly susceptible to L. major infection despite mounting a strong
Th1 (IFN-γ) response (Seger and Krebs, 1995). Interestingly,
an IFN-γ independent immune-protective mechanism has also
been recently proposed. Spath et al. (2009) demonstrated that in
vitro infection of Stat1-deficient macrophages with LPG deficient
(lpg1-) L. major promastigotes resulted in a two-fold increase
in intracellular growth, which was independent of IFN-γ but
was associated with a substantial increase in phagosomal pH.
Besides IFN-γ, a number of other inflammatory cytokines, such
as IL-1, TNF, IFN-α, and IFN-β are also involved in macrophage
activation and upregulation of iNOS expression leading to NO
production (Bronte and Zanovello, 2005).
In contrast classical activation, alternative macrophage activa-
tion is induced by Th2 cytokines, such as IL-4 and IL-13 (Gordon,
2003). It has been shown that IL-4-induced polyamine biosynthe-
sis (via upregulation of arginase) favors L. major parasite survival
in macrophages (Kropf et al., 2005). This finding reinforced the
notion that Leishmania encoded arginase is a virulent factor
and its expression functions to preferentially enhance alternative
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FIGURE 1 | Dendritic cells and macrophages regulate the outcome
of Leishmania infection. Following infection, both macrophages and
dendritic cells phagocytose Leishmania leading to different functional
outcomes. Infected dendritic cells produce IL-12, which is critical for the
development of IFN-γ-producing CD4+ Th1 cells. IFN-γ acts on infected
macrophages leading to their activation (classical activation), upregulation
of iNOS, and production of nitric oxide and other free radicals that are
important for intracellular parasite killing. In contrast, the production of
IL- 4 by other cell types (including keratinocytes and Vβ4 T cells)
supports CD4+ Th2 development. Th2 cells produce IL- 4 and IL-13,
which leads to upregulation of arginase activity, alternative macrophage
activation and the production polyamines that favor intracellular parasite
proliferation. In addition, naturally occurring regulatory T cells (Treg) and
infected macrophages also produce some immunoregulatory cytokines
including IL-10 and TGF-β, which further deactivate infected cells leading to
impaired parasite killing.
macrophage activation leading to parasite survival (Iniesta et al.,
2002, 2005; Kropf et al., 2005). Using arginase deficient L. major,
we found that the influence of parasite-derived arginase on dis-
ease severity is not related to its modulatory effect on the host
immune response (Muleme et al., 2009). Rather, Leishmania-
encoded arginase enhances disease pathogenesis by augmenting
host cellular arginase activities leading to parasite survival and
proliferation in infected macrophages. Thus, contrary to popu-
lar belief, the host cellular arginase activity in L. major-infected
mice may not be regulated by cytokines. Another cytokine that
negatively affects classical macrophage activation is IL-10. It
inhibits the respiratory burst and inflammatory cytokine produc-
tions, particularly TNF, by macrophages (Gordon, 2003), thereby
negatively affect parasiticidal activity of infected cells.
To evade killing by activated macrophages, Leishmania must
manipulate macrophage activation pathways in a way that favor
their survival and proliferation. Interleukin 12 (IL-12) is a criti-
cal cytokine required for CD4+ Th1 development and production
of IFN-γ (Mosmann and Coffman, 1989). IL-12 is mainly pro-
duced by antigen-presenting cells (APCs), and macrophages were
initially proposed as the major source of IL-12 in L. major-
infected mice. Although macrophages phagocytose Leishmania
efficiently, there is evidence that their ability to produce IL-12 is
selectively impaired by the parasites (Reiner, 1994; Carrera et al.,
1996; Desjardins and Descoteaux, 1998). This impairment in
IL-12 production is not strain specific because macrophages from
both the susceptible and resistant strains of mice display similar
degree of impairment in IL-12 production after L. major infec-
tion although other proinflammatory cytokines were only slightly
affected (Reiner, 1994). In addition, infection of macrophages by
Leishmania also leads to the production of immuno-regulatory
cytokines such as IL-10 and TGF-β, cytokines that are known for
their inhibition/deactivation of macrophage functions (von der
Weid et al., 1996; Kane and Mosser, 2000, 2001).
The balance between the host and parasite factors that control
the activation/deactivation of macrophages determines the final
outcome (or fate) of the parasites within infected macrophage. In
line with this, certain parasite-derivedmolecules have been shown
to regulate the outcome of L. major infection in mice. Recently,
we demonstrated that in the absence of phosphoglycan (PG)
containing molecules (as seen in lpg2- L. major), Leishmania par-
asites are unable to induce early IL-4 production in BALB/c mice
(Liu et al., 2009), suggesting that parasite-derived molecules can
modulate host adaptive immune response to favor their survival.
Similarly, Leishmania parasites can also induce the expression
of immunomodulatory molecules, such as CD200, to inhibit
macrophage activation (Cortez et al., 2011). In this report, it was
further demonstrated that CD200-dependent iNOS inhibition
was responsible for the increased virulence of L. amazonensis
(Cortez et al., 2011).
Frontiers in Cellular and Infection Microbiology www.frontiersin.org June 2012 | Volume 2 | Article 83 | 3
Liu and Uzonna Modulation of DCs and macrophage by Leishmania
THE INTERACTION OF LeishmaniaWITH DENDRITIC CELLS
DCs are hematopoietic bone marrow progenitor-derived leuko-
cytes that are highly heterogeneous and widely distributed all over
the body (Banchereau and Steinman, 1998; Steinman, 2007). As
professional and most potent APCs, DCs are specialized in anti-
gen uptake, processing, and presentation to T cells. Although
macrophages are also professional APCs and the main host for
harboring Leishmania parasites as well as effector cells for par-
asite killing, Leishmania-infected macrophages do not secrete
IL-12 (von Stebut et al., 1998) and hence unable to stimulate
antigen-specific CD4+ Th1 cell response (Kima et al., 1996).
Indeed, several reports show a central role for DCs in orches-
trating immune responses in leishmaniasis (Gorak et al., 1998;
von Stebut et al., 1998; Leon et al., 2007). The skin contains at
least three DC populations that consist of epidermal Langerhan
cells and two migratory dermal DC subsets. Early studies demon-
strated that epidermal Langerhan cells (MHC IIhigh, CD11c+,
CD11blow, CD8αinter, CD205high, and Langerin+) phagocytose
L. major in vivo and migrate to draining lymph nodes (dLNs)
for presentation to antigen-specific T cells (Moll et al., 1993).
Surprisingly, however, later studies showed that DCs harboring
parasites in dLNs are Langerin negative, but rather express der-
mal DC markers (MHC IIhigh, CD11c+, CD11b+, CD8α−, and
CD205low) (Ritter et al., 2004), which is the major DC population
that primes CD4+ T cell response. Also, mice genetically modified
to showMHC class II deficiency exclusively in LCs (but not in der-
mal DCs) control L. major infection similar to wild type animals
(Lemos et al., 2004), suggesting that LCs are dispensable for trig-
gering T cell response during Leishmania infection. Moreover, a
more recent paper showed that LCs may even play a pathogenic
role during low dose infection via the induction and expansion of
regulatory T cells (Kautz-Neu et al., 2011). Some studies showed
that parasite harboring dermal DCsmost likely migrate out of the
skin and transport the antigens to the dLNs (Ritter et al., 2004;
Ng et al., 2008). Other studies suggested that blood monocyte-
derived DC may differentiate within the inflamed skin following
a Sandfly bite, phagocytose parasites, and transport them to the
dLN where they present parasite-derived antigen to T cells (Leon
et al., 2007).
The production of IL-12 by APCs is critically important for
polarization of naive T cells toward Th1 subset and subsequent
IFN-γ production (von Stebut et al., 1998). Infection of DC with
Leishmania results in functional IL-12p70 production (Marovich
et al., 2000). Interestingly, different DC subsets are differentially
permissive to Leishmania parasites and this differential infectivity
seems to be inversely correlated with the ability of infected cells to
produce IL-12p70 (Henri et al., 2002). CD8α+ DCs are the least
permissive to L. major amastigotes compared to CD8α− DCs and
CD8α− DCs. However, CD8α+ DCs are the most powerful IL-
12p70 producers in response to infection (Henri et al., 2002). The
mechanism(s) that control the induction of IL-12 from DCs and
the functional differences between the IL-12-producing DCs and
the non-producers are still not yet known.
It has been speculated that the different outcome of
Leishmania infection in the resistant and susceptible mice may
be related to differences in their DC function, particularly in
promoting the differentiation of naïve CD4+ helper T cells into
effector cells (Suzue et al., 2008). However, von Stebut et al. (1998)
demonstrated that L. major-infected fetal skin-derived DCs from
both BALB/c and C57BL/6 mice upregulate their constimula-
tory molecules and produce comparable levels proinflammatory
cytokines, including IL-12p70. In contrast, Moll et al. (2002)
showed that epidermal-derived DCs (Langerhans cells) from
BALB/c mice up-regulate IL-4 receptor expression and down-
regulate IL-12p40 production in response to L. major infection,
suggesting that Leishmania parasites have evolved strategies to
inhibit DC Th1 polarizing functions. Baldwin et al. (2004) found
that L. major-infected BALB/c mice have an increased number
of plasmacytoid DCs in their dLNs and this was associated with
higher cell recruitment early after infection compared to infected
C57BL/6 mice. However, it is not clear whether the observed
differences in DCs between susceptible and resistant mice are
relevant to the pathogenesis of disease. At present, there is still
limited information on initial DC responses to other species
of Leishmania at the site of infection and their contribution to
priming of protective or pathogenic T cell responses.
Toll like receptors (TLRs) are important pattern recognition
receptors (PRRs) that are not only involved in self/non-self dis-
crimination by the innate arm of host immunity, but also at
initiating and directing subsequent adaptive immunity. TLRs are
expressed abundantly on macrophages, DCs, and NK cells. Upon
recognition of respective pathogen associated molecular patterns
(PAMPs), TLRs recruit adaptor molecules, such as MyD88 and
TRIF, and initiate a series but highly coordinated downstream sig-
naling events that lead to the production of pro-inflammatory
cytokines, chemokines, and antimicrobial peptides (Kawai and
Akira, 2010). MyD88 participates in most TLRs’s signal trans-
duction by binding to the cytoplasmic domain of Toll/IL-1 like
receptor (Takeda andAkira, 2004). de Veer et al. (2003) found that
MyD88 deficient C57BL/6 mice were more suscepitble to L. major
infection, suggesting a critical role of TLR signaling in initiating
anti-Leishmania immunity. They further demonstrated that LPG,
the major and most abundant surface molecule of Leishmania, is
a TLR2 ligand, and is responsible for the generation of protec-
tive immunity against leishmaniasis. To date, three distinct TLRs,
TLR2, TLR4, and TLR9, have been suggested to be involved in
the recognition of L. major (de Veer et al., 2003; Kropf et al.,
2004; Liese et al., 2007; Schleicher et al., 2007; Abou Fakher et al.,
2009). However, a recent study (Abou Fakher et al., 2009), using
C57BL/6 mice deficient in either TLR2, 4, or 9, showed that only
TLR9-deficient mice are more susceptible to L. major infection,
indicating that the reported role of TLR2 and TLR4 in immunity
to murine leishmaniasis needs to be re-evaluated. It is also not
clear whether TLR deficiency specific to DCs or macrophages will
likely have any effect on the outcome the disease.
SUBVERSION OF HOST MACROPHAGE AND DC
INTRACELLULAR SIGNALING PATHWAYS BY
Leishmania
Intracellular signaling events leading to the activation of genes
involved in production of effector molecules are important for
efficient and effective control of pathogens by host infected
cells. A number of pathogens are able to manipulate the sig-
nal transduction pathways of their host cells to favor their
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survival (Harnett et al., 1999; Tachado et al., 1999; Sibley, 2011).
Since Leishmania are obligate intracellular parasites, their survival
inside its mamalian host cells is critically dependent on their abil-
ity to successfully disrupt the host cell signaling events that lead
to the generation of effector molecules. To evade killing by the
host, the parasites are actively involved in almost every aspects
of the manipulation/inhibition of host cell signalling, rang-
ing from preventing the production of microbicidal molecules,
and protective cytokines to interferring with effective antigen
presentation.
In response to cytokines such as IFN-γ and TNF, macrophages
become activated and producemicrobicidal free radicalmolecules
such as NO and reactive oxgen intermediates (Figure 1). In addi-
tion, activated macrophages also produce TNF, which acts in an
autocrine manner to further enhance the production of micro-
bicidal free radicals by macrophages. The critical role of NO is
confirmed in iNOS deficient mice whose macrophages are unable
to eliminate parasites in vitro and these mice are also highly sus-
ceptible to Leishmania (Seger and Krebs, 1995). Protein kinase C
(PKC) is known to play a key role in the regulation of macrophge
functions including production of proinflammatory cytokines,
NO, and reactive oxygen intermediates (ROI). By using murine
macrophage cell line overexpressing a dominant-negative (DN)
mutant of PKC-α, St. Denis et al. (1999) found that although
phagocytosis of L. donovani promastigotes was not altered by DN
PKC-α overexpression, intracellular survival of the parasites was
significantly enhanced. This observation suggests that PKC sig-
naling is critical for macrophage activation and parasite killing
by infected cells. In line with this, early studies showed that the
abundant promastigote surface protein, LPG, is able to block the
bio-activity of PKC (Severn et al., 1992). However, another study
(Olivier et al., 1992) questioned the role of LPG in the blockage
of PKC function, by using amastigotes which lack or have highly
reduced levels of LPG on their surface. In this report, amastigotes
were still capable of efficiently inhibiting PKC activity in mono-
cytes, suggesting that other parasite molecules or factors may be
involved in modulating PKC activity. Another parasite molecule
that has been implicated in the downregulation of intracellular
signaling cascade in macrophages resulting in the suppression of
macrophage microbicidal activities is gp63 (Sorensen et al., 1994;
Descoteaux and Turco, 1999). GP63 is a 63 kDa zinc-dependent
metalloproteinase that is abundantly expressed on the cell surface
of all Leishmania promastigotes (Yao et al., 2003), and is about 10
times less abundant than LPG (McConville and Blackwell, 1991;
Pimenta et al., 1991). Recent studies show that a number of host
cell signaling molecules, particularly protein tyrosine kinases, are
either proteolytically processed or modulated by gp63 (Gomez
et al., 2009; Halle et al., 2009). Thus, the expression of gp63 activ-
ity is potentially another possible evasion strategy of Leishmania
parasites.
Leishmania has also been shown to downregulate the acti-
vation of mitogen-activated protein kinases (MAPKs), a group
of enzymes that regulate macrophage functions including the
production of proinflammatory cytokines and NO (Seger and
Krebs, 1995). Infection of macrophages with L. donovani leads to
alteration of MAPK activities resulting in active downregulation
of proinflammatory cytokine production (Nandan et al., 1999).
This effect was shown to be mediated by L. donovani-dependent
induction of protein tyrosine phosphatases (PTPs) (Blanchette
et al., 1999; Forget et al., 2006). In line with this observation,
the activation of MAPK and production of proinflammatory
cytokines was restored to normal levels in L. donovani-infected
SHP-1 deficient macrophages (Forget et al., 2006). The induction
of PTPs and inhibition of MAPK in macrophages has been asso-
ciated with the promastigote-specific surface molecules because
infection of macrophages with LPG deficient Leishmania leads
to robust activation of ERK, although this has minimal effect
on p38 and JNK activation (Dermine et al., 2000; Prive and
Descoteaux, 2000). In contrast, Balaraman et al. (2005) using
immortalized macrophage cell line, found that LPG has a stim-
ulatory effect on macrophages leading to increased activation of
MAPKs. These differences might be related to the use of dif-
ferent cells in these studies; primary versus immortalized cell
lines.
In addition to downregulation of MAPK, Leishmania also
inhibits the JAK/STAT signaling pathways. JAK2/STAT1 signal-
ing pathway is critically important for proper and optimal
macrophage response to IFN-γ, which leads to the production
of cytotoxic molecules for killing intracelular pathogens, includ-
ing Leishmania. Nandan and Reiner (1995) showed that infection
of human monocytic cell line and peripheral blood monocytes
with L. donovani leads to dramatic impairment in IFN-γ-induced
tyrosine phosphorylation. This effect was mediated via selective
inhibition of JAK/STAT1 signaling pathway (Nandan and Reiner,
1995).
Likemacrophages, Leishmania also interferes with intracellular
signaling in DCs, which affects their antigen-presenting functions
and hence their ability to induce optimal cell-mediated immu-
nity against the parasite (Soong, 2008; Xin et al., 2008). Studies
show that L. amazonensis amastigotes can suppress cytokine- and
TLR-4-mediated DC activation and IL-12 production via rapid
degradation of intracellular signaling proteins, particularly those
associated with the JAK/STAT, NFκB, and interferon regulatory
factor (IRF) pathways (Xin et al., 2008). The cathepsin-like cys-
teine proteinases in the parasite are believed to be responsible
for the downregulation of NFκB signaling and hence IL-12 pro-
duction in macrophages (Cameron et al., 2004). Whether these
molecules are also involved in modulating NFκB signaling and
IL-12 production in DCs is still not known. Interestingly, it
has been shown that the alteration of DC response to L. ama-
zonensis infection (including CD40 expression and IL-12 pro-
duction) was mediated by the activation of ERK, a member of
MAPK (Boggiatto et al., 2009). Thus, these reports suggest that
the mechanisms through which Leishmania impair signaling in
macrophages and DCs may be different.
CONCLUDING REMARKS
Although multiple cellular components are involved in the
immune response against leishmaniasis, there is no question that
macrophages and DCs play critical roles in the initiation, devel-
opment, and maintenance of a protective immunity (Figure 1).
It is quite clear that the production of IL-12 by DCs initi-
ates Th1 response and protective immunity by promoting early
NK cell activities (including IFN-γ production and cytotoxicity)
Frontiers in Cellular and Infection Microbiology www.frontiersin.org June 2012 | Volume 2 | Article 83 | 5
Liu and Uzonna Modulation of DCs and macrophage by Leishmania
(Liese et al., 2007). However, the exact mechanisms driving dif-
ferentiation of naive CD4+ T cells into Th1 or Th2 phenotypes
are still not very clear but are likely to be dictated by the
cytokine environments during the early hours after infection
(Sokol et al., 2008). On the other hand, the parasite also uses
a variety of strategies to manipulate macrophage and DC func-
tions to favor their survival and replication. One of the major
mechanisms used by Leishmania is to inhibit the production
of Th1-polarizing cytokine, IL-12, as well as preventing DCs
from successfully presenting parasite antigens to T cells result-
ing in impaired cell-mediated immunity. Thus, the interplay
between APCs (macrophages and DCs) and Leishmania para-
sites is complex. The parasite must infect these cells in order to
proliferate and survive, but these infected cells are also critical
for presenting parasite-derived antigens to T cells to initiate cell-
mediated immunity, which is detrimental for the parasite. Given
the fact that the disease pathology is highly variable depending
on the species of Leishmania, it is very hard to generalize spe-
cific modulatory mechanism(s) to all strains and in all hosts.
This is important because most of the studies investigating the
role of DCs/macrophages (and their modulation thereof) dur-
ing Leishmania infection usually conducted with a single specie
of the parasite in one strain of mice, which precludes multi-
species/strain comparison. A more comprehensive study would
be very helpful for a better understanding of the role of these cells,
themechanisms that regulate their antigen presentation functions
and pathogen factors that influence antigen presentation and sub-
sequent activation of the adaptive immune system. This would be
beneficial in the design of new drugs and therapies to control this
disease.
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